Discussion of prescription to over-the-counter switches for inhaled products from a patient, business, and regulatory perspective was one of several topics on display at Respiratory Drug Delivery (RDD) Europe 2015, which hosted 450 pulmonary and nasal drug delivery experts from 31 countries at its latest conference in Antibes from May 5 to May 8.
In addition, RDD Europe celebrated its 10th anniversary, although its parent United States conference began in 1988.
As the market for self-administered drug-delivery devices continues to grow, there is a labor shortage affecting original equipment manufacturers (OEM). Phillips-Medisize CEO Matt Jennings discussed the impact of the shortage and strategies for OEMs to remain innovative at an industry briefing during Pharmapack North America and MD&M East.
Mylan announced the launch of the first bioequivalent alternative to GlaxoSmithKline’s Seretide Evohaler (salmeterol xinafoate/fluticasone propionate) in June under the brand name Sirdupla in the UK, reports 3M Drug Delivery Systems. It is a pressurized metered-dose inhaler to treat or prevent symptoms of asthma in adults 18 years of age and older.
The product is being manufactured by 3M.
Pharmapack North America was held June 9-10 at the Javits Center in New York City, featuring more than 30 exhibitors in the pharmaceutical packaging industry along with dozens of industry speakers. Click back through the coverage PMP News completed of its speakers and exhibitors for the 2015 show.
Here's a look at the show in photos:
Phillips-Medisize Corporation announced the opening of its new design and development center in Suzhou, China. Growth of the company’s design and development centers are claimed to help support customer needs for patient-administered biologics, pharmaceutical drug delivery, and diagnostics device design and development services.
Pharmapack North America was held June 9-10 at New York City’s Jacob K. Javit’s Convention Center.
Here are the latest reports on the exhibitors, products, and speakers published on the event:
When it comes to today’s injectable and inhalable therapies, drug administration won’t necessarily be kept under the control of a professional, observes Bill Welch, chief technology officer for Phillips-Medisize Corp. “Drug administration will increasingly be placed in the hands of a patient,” he says.
Aptar Pharma, a business segment of Aptar developing solutions for biotechnology, healthcare, and pharmaceutical companies, will be presenting its Pro-Ject auto injector and PremiumCoat at Pharmapack North America on June 9-10 in New York. Pro-Ject is from Aptar Pharma Prescription, and PremiumCoat is from Aptar Stelmi.
Aptar will be manning booth 4004 at the conference.
Sandoz, the generic division of Novartis, announced the opening this month of the Sandoz Packaging Center in Stryków, a project valued at $48 million.
It is one of the largest investment projects in the Polish pharmaceutical sector completed in recent years, according to a press release from Sandoz.
Gerresheimer, special glass and plastics manufacturer, presented its application aid, DropAid, along with new pharmaceutical plastics products at FCE Pharma in São Paulo, Brazil from May 12-14.
“DropAid is an application aid for daily use,” said Wellington Lentini, general manager of Gerresheimer Plásticos São Paulo Ltda, in a press release. “Do you know how difficult it is to use a typical eye dropper? [DropAid] helps dropper bottle users to open the bottle and, when placed on the bottle neck, makes it easy and simple to positioning the dropper correctly above the eye.”